Loading...
XSTOSERT
Market cap20mUSD
Dec 23, Last price  
1.12SEK
1D
7.69%
1Q
5.66%
Jan 2017
-78.00%
IPO
-54.69%
Name

Serstech AB

Chart & Performance

D1W1MN
XSTO:SERT chart
P/E
323.78
P/S
3.68
EPS
0.00
Div Yield, %
0.00%
Shrs. gr., 5y
12.10%
Rev. gr., 5y
42.82%
Revenues
63m
+267.65%
911,497491,1181,131,8902,700,97817,496,22116,805,68110,588,10118,742,15320,488,00018,651,00017,112,00062,913,000
Net income
715k
P
-839,375-3,543,243-8,402,447-8,116,858-6,417,469-2,547,047-12,330,561-15,877,170-6,730,000-10,252,000-29,566,000715,000
CFO
8m
P
-1,866,43300005,893,000-11,823,000-10,586,0003,558,000-628,000-13,158,0007,631,000

Profile

Serstech AB provides chemical identification instruments worldwide. It offers the Serstech 100 Indicator, a handheld, small, and light Raman spectrometer for measuring chemicals, such as explosives, narcotics, toxic industrial chemicals, pharmaceuticals, and chemical warfare agents; and ChemDash, a central management software for Serstech devices. The company also provides Serstech Arx and Serstech Arx+ revolutionizing instruments for quick and precise identification of chemical substances; and Serstech's SERS kit that allows for quick identification of low concentrations and narcotics samples. It offers its solutions for explosive, CBRN and hazmat, narcotics, and pharma applications. Serstech AB was incorporated in 2006 and is headquartered in Lund, Sweden.
URL
https://serstech.com/
IPO date
Aug 29, 2013
Employees
20
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
62,913
267.65%
17,112
-8.25%
18,651
-8.97%
Cost of revenue
14,320
28,670
16,442
Unusual Expense (Income)
NOPBT
48,593
(11,558)
2,209
NOPBT Margin
77.24%
11.84%
Operating Taxes
37
80
(6)
Tax Rate
0.08%
NOPAT
48,556
(11,638)
2,215
Net income
715
-102.42%
(29,566)
188.39%
(10,252)
52.33%
Dividends
Dividend yield
Proceeds from repurchase of equity
20,917
22,481
BB yield
-25.33%
-17.29%
Debt
Debt current
1,800
739
1,699
Long-term debt
4,000
Deferred revenue
Other long-term liabilities
802
216
118
Net debt
(16,672)
182
(45,039)
Cash flow
Cash from operating activities
7,631
(13,158)
(628)
CAPEX
(318)
(7,590)
(12,562)
Cash from investing activities
(9,003)
(7,590)
(12,555)
Cash from financing activities
17,978
3,040
21,361
FCF
44,783
(8,453)
2,255
Balance
Cash
18,472
1,866
19,574
Long term investments
2,691
27,164
Excess cash
15,326
3,701
45,805
Stockholders' equity
(72,605)
(87,255)
9,429
Invested Capital
123,179
118,631
48,187
ROIC
40.16%
3.08%
ROCE
96.08%
3.83%
EV
Common stock shares outstanding
145,918
83,816
92,869
Price
0.57
102.14%
0.28
-80.00%
1.40
-36.55%
Market cap
82,590
251.92%
23,469
-81.95%
130,017
-32.29%
EV
65,918
23,707
152,280
EBITDA
60,538
(3,525)
9,061
EV/EBITDA
1.09
16.81
Interest
284
209
147
Interest/NOPBT
0.58%
6.65%